News Author: HT Staff Publish date: October 10, 2014
The US Food and Drug Administration (FDA) has approved bortezomib (Velcade) for use in previously untreated patients with mantle cell
lymphoma (MCL)....
News Author: HT Staff Publish date: October 9, 2014
Credit: Chad McNeeley
Combining a couple of “promising” treatment approaches can prevent graft-vs-host disease (GVHD) as well as conventional thera...
News Author: HT Staff Publish date: October 9, 2014
Credit: Steven Harbour
The recent surge in spending on oral anticancer drugs in the US exceeds the increase in use of these drugs, new research sho...
News Author: HT Staff Publish date: October 9, 2014
Credit: Max Planck Institute
for Biophysical Chemistry
Three scientists have received the 2014 Nobel Prize in Chemistry for aiding the development...
News Author: HT Staff Publish date: October 9, 2014
Credit: Chad McNeeley
A new gene therapy appears safe and effective for boys with X-linked severe combined immunodeficiency syndrome (SCID-X1).
...
News Author: HT Staff Publish date: October 8, 2014
Credit: St Jude Biomedical
Communications
Risk-directed therapy can level the playing field for patients with BCR-ABL1-like acute lymphoblastic le...
News Author: HT Staff Publish date: October 8, 2014
The US Food and Drug Administration (FDA) has authorized the use of a pathogen inactivation system in regions of the US and its territories affected b...
News Author: HT Staff Publish date: October 8, 2014
chemotherapy
Credit: Rhoda Baer
In a large German study, investigators found that nearly a third of cancer patients experienced some form of clini...
News Author: HT Staff Publish date: October 8, 2014
Credit: Petr Kratochvil
A federal program designed to help the poor may actually be used to help US hospitals increase their profits, according to ...
News Author: HT Staff Publish date: October 7, 2014
Credit: Aaron Logan
Scientists have found that a single cell containing the JAK2-V617F mutation can cause myeloproliferative neoplasms (MPNs) in mi...
News Author: HT Staff Publish date: October 7, 2014
However, the combination did confer a survival benefit when transplant patients were excluded from the analysis and in patients age 60 and older.
R...
News Author: HT Staff Publish date: October 7, 2014
californica releasing ink
after being disturbed
Results of preclinical research appear to explain how the anticancer agent doxorubicin can cause c...
News Author: HT Staff Publish date: October 7, 2014
Credit: Bill Branson
Healthcare professionals do not consistently follow the recommended safe handling practices for antineoplastic drugs, accordin...
News Author: HT Staff Publish date: October 6, 2014
allows scientists to identify
differences in blood cell origin
Credit: Camargo Lab
By developing a tracking system for stem cells, researchers ma...
News Author: HT Staff Publish date: October 6, 2014
Credit: Linda Bartlett
In a new draft guidance, the UK’s National Institute for Health and Care Excellence (NICE) has said it cannot recommend obin...
